ClinicalTrials.govpublic full text
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
ovarian cancer, melanoma, triple negative breast cancer, colorectal cancer, solid tumors,nm1f,pembrolizumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829476
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.